Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Semin Pediatr Surg. 2020 Jul 23;29(4):150945. doi: 10.1016/j.sempedsurg.2020.150945

Table 2.

Treatable causes of neonatal cholestasis

Disorder Treatment
Infection (viral, bacterial, spirochete, parasite) Antimicrobials
Galactosemia Galactose-free diet
Tyrosinemia type 1 NTBC (2-(2- nitro-4-trifluoromethylbenzol)-1,3-cyclohexanedione), low tyrosine or phenylalanine diet
Hereditary fructose intolerance Fructose or sucrose free diet
Hypothyroidism Thyroid hormone replacement
Cystic fibrosis Pancreatic enzymes
Hypopituitarism Thyroid, growth hormone, cortisol replacement
Bile acid synthesis defects Cholic acid or ursodeoxycholic acid supplementation
Biliary atresia Hepatoportoenterostomy (Kasai procedure)
Choledochal cyst Mucosectomy and Choledochoenterostomy
Spontaneous perforation of the common bile duct Surgical drainage
Inspissated bile, common bile duct stone Biliary tract irrigation
Parenteral nutrition associated cholestasis (intestinal failure associated cholestasis) Intravenous lipid emulsion modification, advance enteral feedings

Adapted from Feldman AG, Sokol RJ, Nat Rev Gastroenterol Hepatol, 2019: Table 153